Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Mar 29, 2018 (9 years ago)

Zhong Hua Jiu

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: the product was produced with substandard GMP manufacturing processes.

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Zhong Hua Jiu (menthol 1%) Patch, Distributed by United Pacific Company, UPC 6 924938 100226, NDC 53614-001-02

Affected NDC 53614-0001-02

Compare with the code on your package — it is the most precise check available.

Drug: Menthol

Recalling firm
United Pacific Co Ltd
NDC code
53614-001-02
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0624-2018 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Menthol recalls

See all
Class II · Moderate risk

Zicam

CGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testing

Ongoing Microbial contamination Church & Dwight Co., Inc. D-0790-2026

Other cgmp deviation recalls from 2018

All cgmp deviation recalls
Class II · Moderate risk

Oxygen

CGMP Deviations

Terminated cGMP deviation Roberts Home Medical LLC D-1002-2019
Class II · Moderate risk

Cidofovir Dihydrate

CGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.

Terminated cGMP deviation LGM Pharma LLC D-0486-2019